Cite
Wong DJ, Robert L, Atefi MS, et al. Erratum to: Antitumor activity of the ERK inhibitor SCH722984 against BRAF mutant, NRAS mutant and wild-type melanoma. Mol Cancer. 2015;14:128doi: 10.1186/s12943-015-0393-2.
Wong, D. J., Robert, L., Atefi, M. S., Lassen, A., Avarappatt, G., Cerniglia, M., Avramis, E., Tsoi, J., Foulad, D., Graeber, T. G., Comin-Anduix, B., Samatar, A., Lo, R. S., & Ribas, A. (2015). Erratum to: Antitumor activity of the ERK inhibitor SCH722984 against BRAF mutant, NRAS mutant and wild-type melanoma. Molecular cancer, 14128. https://doi.org/10.1186/s12943-015-0393-2
Wong, Deborah J L, et al. "Erratum to: Antitumor activity of the ERK inhibitor SCH722984 against BRAF mutant, NRAS mutant and wild-type melanoma." Molecular cancer vol. 14 (2015): 128. doi: https://doi.org/10.1186/s12943-015-0393-2
Wong DJ, Robert L, Atefi MS, Lassen A, Avarappatt G, Cerniglia M, Avramis E, Tsoi J, Foulad D, Graeber TG, Comin-Anduix B, Samatar A, Lo RS, Ribas A. Erratum to: Antitumor activity of the ERK inhibitor SCH722984 against BRAF mutant, NRAS mutant and wild-type melanoma. Mol Cancer. 2015 Jul 02;14:128. doi: 10.1186/s12943-015-0393-2. PMID: 26134498; PMCID: PMC4488977.
Copy
Download .nbib